Logo

Pharmaxis to Use Dotmatics' Data Mining Platform

Jan 11, 2012

NEW YORK (GenomeWeb News) – UK-based Informatics firm Dotmatics said today that drug maker Pharmaxis will use its data-mining platform to manage its preclinical research data.

Dotmatics' Browser is an interactive dashboard for integrating and viewing research data from disparate sources, and its Vortex application offers predictive analytics, and data visualization and analysis applications.

Financial terms of the agreement were not released.

Pharmaxis is a specialty pharmaceutical firm that focuses on drugs for respiratory diseases.

Filed under

Informatics
data mining
Dotmatics
Breaking News
The Scan

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.

Study Reviews Family, Provider Responses to Rapid Whole-Genome Sequencing Follow-up

Investigators identified in the European Journal of Human Genetics variable follow-up practices after rapid whole-genome sequencing.

BMI-Related Variants Show Age-Related Stability in UK Biobank Participants

Researchers followed body mass index variant stability with genomic structural equation modeling and genome-wide association studies of 40- to 72-year olds in PLOS Genetics.

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.